This Cochrane Group is no longer active

Due to changes in NIHR funding in evidence synthesis, this Cochrane Group is no longer active. We are so grateful for the work of our contributors.

If you would like to get involved with Cochrane, please visit our Join Cochrane pages.

To learn more about Cochrane, visit our homepage.

If you would like to propose a topic for a Cochrane Review, please see our instructions for authors.

If you have any queries, please contact Cochrane Support.

Neuromuscular priority setting

Cochrane Neuromuscular aims to publish relevant, up to date systematic review evidence in Neuromuscular Disease to support anyone making decisions about health care.

Our 187 registered review titles range from regularly updated published reviews to newly registered titles yet to become a protocol. As a small group, it has become necessary to identify the most important among our titles – we need to target our resources effectively and ensure the relevance and usefulness of our evidence. To enable this, we conducted a priority setting exercise in 2020. From this we have a 'long list' of reviews and updates judged to be high priority, from which we will publish 20 to 30 reviews over the next three years.

The process has two aspects:

  • to identify priorities for updating published reviews and completion of ongoing reviews;
  • to identify gaps where reviews are needed. 

We drafted a Priority Setting Plan and completed a priority setting exercise with clinical experts. We have also consulted consumer organisations in specific topic areas. The plan follows Scenario 2 in the Cochrane Priority Setting Guidance Note.  

We will repeat the priority setting exercise every three years. However, priorities that emerge in the interim will be incorporated in our plans.

If you have any comments or would like your organisation to be considered as a stakeholder in this process, please get in touch with the Managing Editor cochranenmd@ion.ucl.ac.uk.